MMP9 and breast carcinoma: The encouraging data obtained by the in silico analysis confirmed by the enzymatic inhibition assay, provided a rationale for the in vitro investigation on human MDA-MB-231 breast cancer cells, characterized by a marked invasive phenotype, supported by a high constitutive expression of several MMPs, especially MMP-9 [26].